Related Experiment Videos
[Respiratory diseases and oxidants]
1Division de pneumologie, CHUV, Lausanne.
Schweizerische Medizinische Wochenschrift
|January 29, 1994
Summary
Oxidants contribute to many human disorders, particularly lung diseases. Oral N-acetylcysteine effectively corrects oxidant-antioxidant imbalances, offering a therapeutic approach.
Area of Science:
- Biochemistry
- Pulmonology
- Toxicology
Context:
- Oxidants, from internal and environmental sources, are implicated in numerous human disorders.
- Chronic oxidant stress is a significant factor in various pulmonary diseases, including COPD, asthma, and ARDS.
- Current therapeutic strategies for managing oxidant-induced damage remain a clinical challenge.
Purpose:
- To investigate the role of oxidants in human diseases.
- To evaluate N-acetylcysteine as a therapeutic intervention for oxidant-antioxidant imbalance.
Summary:
- Oxidants, released by inflammatory cells or from environmental factors like pollution and smoke, contribute to various health issues.
- Persistent oxidant stress is linked to severe pulmonary conditions such as adult respiratory distress syndrome, COPD, asthma, emphysema, and interstitial fibrosis.
- Oral administration of N-acetylcysteine presents a straightforward and effective method for restoring the balance between oxidants and antioxidants.
Impact:
- Highlights the critical role of oxidants in disease pathogenesis.
- Identifies N-acetylcysteine as a promising therapeutic agent for conditions associated with oxidative stress.
- Suggests a potential clinical strategy for managing oxidant-related disorders, particularly in pulmonology.